Hema Tallman Congratulates Richard Wilner on Receiving the Sustainability in Life Sciences Award
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”Please join me in congratulating Richard Wilner, Head of Transformation and Sustainability at BioLife Plasma Services, part of Takeda, for receiving the Sustainability in Life Sciences Award at the 4th Annual Life Sciences Leadership Summit hosted by Campana and Schott USA and the German American Chamber of Commerce, Inc. – GACC New York.
Rich, along with the collective efforts of cross-functional teams, has helped shape BioLife’s contributions to reaching Takeda’s environmental goals:
– Reach net-zero greenhouse gas emissions in operations by 2035.
– Reach net-zero greenhouse gas emissions across our entire value chain by 2040.
– Send zero waste to landfill by 2030.
I’ve had the privilege of working alongside Rich, and I’m continually inspired by his bold thinking and his ability to foster innovation that spurs action.
Thank you, Rich, for your tireless passion and being a champion of meaningful change across our organization and industry and for our patients.”
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country
-
Dec 16, 2025, 11:03Matías J Alet on CABOS Project with The Support of WSO
-
Dec 16, 2025, 00:32New on EHCucate: Read about the “History of Replacement Factor Therapies” and More